Autoimmune hemolytic anemia: the current state of the issue
Open Access
- 28 May 2023
- journal article
- research article
- Published by Publishing House ABV Press in Oncohematology
- Vol. 18 (2) , 60‑67
Abstract
Autoimmune hemolytic anemia is a rare disease characterized by the appearance of anti-erythrocyte autoantibodies and subsequent destruction of red blood cells by cells of the immune system. The destruction mechanisms of erythrocytes loaded with autoantibodies are well studied; however, the initial mechanisms that trigger the production of antibodies to own erythrocytes antigens remain unclear. In the pathogenesis of autoimmune hemolytic anemia, an important role is played by impaired immunological tolerance, in which T-lymphocytes play a key role. The study of T-lymphocytes subpopulation in patients with autoimmune hemolytic anemia by flow cytometry can provide valuable information for studying the disease pathogenesis and developing new approaches to its treatment.Keywords
This publication has 44 references indexed in Scilit:
- How I manage cold agglutinin diseaseBritish Journal of Haematology, 2011
- High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin diseaseBlood, 2010
- Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cellsNature Immunology, 2009
- Cell Death Mechanisms Induced by Cytotoxic LymphocytesCellular & Molecular Immunology, 2009
- Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subsetNature Immunology, 2008
- Immune Hemolytic Anemia—A PrimerSeminars in Hematology, 2005
- Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patientsBlood, 2004
- CTLA‐4 exon 1 polymorphism in patients with autoimmune blood disordersAmerican Journal of Hematology, 2003
- Reduced frequency of HLA‐DQ6 in individuals with a positive direct antiglobulin testTransfusion, 1996
- Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patientsAmerican Journal of Hematology, 1993